Eos Focused Equity Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Eos Focused Equity Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-82,028	Closed	-$4.39M	–	31
2016 Q1	$4.39M	Buy	82,028 +4,495	+6%	+$264K	4.02%	8
2015 Q4	$5.09M	Sell	77,533 -10,567	-12%	-$653K	4.38%	10
2015 Q3	$4.97M	Hold	88,100	–	–	4.6%	6
2015 Q2	$5.21M	Hold	88,100	–	–	4.54%	5
2015 Q1	$5.49M	Buy	+88,100	New	+$5.12M	4.52%	4

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eos Focused Equity Management's TEVA Position: Q2 2016 in Review

Eos Focused Equity Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2016, closing a stake of 82,028 shares — an estimated $4.39M sold.

Eos Focused Equity Management first reported a position in TEVA in Q1 2015 and held it in 5 quarters. The position peaked at $5.49M in Q1 2015. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

Eos Focused Equity Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2016 after selling out during the quarter.
Eos Focused Equity Management sold 82,028 Teva Pharmaceutical Industries Limited shares in Q2 2016, an estimated $4.39M.
Eos Focused Equity Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2015 and held it in 5 quarters.
Eos Focused Equity Management's Teva Pharmaceutical Industries Limited position peaked at $5.49M in Q1 2015.
813 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2016.

Based on Eos Focused Equity Management's 13F filing for Q2 2016, filed 9 Aug 2016.